Cite
HARVARD Citation
Tabernero, J. et al. (n.d.). LBA-002Overall survival results from a phase III trial of trifluridine/tipiracil versus placebo in patients with metastatic gastric cancer refractory to standard therapies (TAGS). Annals of oncology. p. . [Online].